← Open Payments lookup

SCOTT ARBAUGH: Open Payments

NPI 1861553513 · O FALLON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$34,951 in 175 payments from 17 companies in 2025. Trend: 2023 $19,008 · 2024 $38,300 · 2025 $34,951

Speaker / faculty: $31,289Food & beverage: $2,848Travel & lodging: $815
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.48$23,588
ABBVIE INC.47$9,881
E.R. Squibb & Sons, L.L.C.17$363
Axsome Therapeutics, Inc.11$212
Alkermes, Inc.10$190
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$165
Collegium Pharmaceutical, Inc.8$154
Neurocrine BioSciences, Inc.4$93
Sage Therapeutics, LLC4$77
Takeda Pharmaceuticals U.S.A., Inc.3$58

Products named: REXULTI, VRAYLAR, COBENFY, Auvelity, ARISTADA, CAPLYTA, Jornay PM, INGREZZA.

Industry payments across MO — which companies pay providers there.